Efficacy of an ivermectin controlled‐release capsule against nematode and arthropod endoparasites in sheep

Five controlled trials were conducted in Germany or in the United Kingdom, using 74 female sheep of merino or Dorset horn breeds, to evaluate the efficacy of an ivermectin controlled‐release capsule against naturally acquired or induced infections of gastrointestinal nematodes, lungworms and nasal bot larvae and against incoming infections with gastrointestinal and pulmonary nematodes. Half of the animals were treated with one ivermectin controlled‐release capsule that delivered ivermectin at the rate of 1.6 mg per day for 100 days while the other half remained untreated. Parasites were counted 21, 28, 35 or 56 days after administration of the capsule. The treatment was highly effective (≥99 per cent) against established parasites of the following species: Haemonchus contortus (adults and fourth‐stage larvae), Ostertagia circumcincta, O pinnata, O trifurcata, Ostertagia species fourth‐stage larvae, Trichostrongylus axei, T colubriformis, T vitrinus, Cooperia curticei, Nematodirus battus, N filicollis, Strongyloides papillosus, Chabertia ovina, Oesophagostomum venulosum, Trichuris ovis, Tr skrjabini, Dictyocaulus filaria, Protostrongylus rufescens and Oestrus ovis (larvae). The treatment prevented the establishment of the gastrointestinal nematodes H contortus, O circumcincta, T axei, T colubriformnis, C curticei, N battus, N filicoliis, Ch ovina, Oe venulosum and the establishment of the lungworm D filaria by >99 per cent compared with untreated controls (P<0.01).